Gastroenterology Department, POVISA Hospital, Vigo, Spain.
Dig Liver Dis. 2012 Nov;44(11):904-8. doi: 10.1016/j.dld.2012.06.008. Epub 2012 Jul 12.
BACKGROUND: The use of complementary and alternative medicine in inflammatory bowel disease patients is progressively increased. AIM: To evaluate the use of complementary and alternative medicine in inflammatory bowel disease patients and to know potential risk factors for their use. The subjective response of these therapies and the impact on treatment adherence were also evaluated. METHODS: Prospective, descriptive and transversal study. Inflammatory bowel disease patients were classified according to demographic and clinical characteristics. A questionnaire about the use of complementary and alternative medicine was collected. RESULTS: 705 patients were included. 126 patients (23%) had used complementary and alternative medicine. The most commonly used was herbal remedies (n=61), homoeopathy (n=36), acupuncture (n=31), kefir (n=31) and aloe vera (n=25). Factors associated with its use were extraintestinal manifestations (OR 1.69, CI 95% 1.11-2.57) and long-term evolution of the disease (OR 2.08, CI 95% 1.44-2.99). Most patients (74%) had the subjective feeling that use of complementary and alternative medicine had not improved their condition, 11 had adverse events related to its use and 11% of patients discontinued their conventional drugs. CONCLUSIONS: Use of complementary and alternative medicine in inflammatory bowel disease patients is frequent, especially in those with extraintestinal manifestations and long-term evolution. The use of these therapies was not perceived as a benefit for patients.
背景:在炎症性肠病患者中,补充和替代医学的应用逐渐增加。
目的:评估炎症性肠病患者中补充和替代医学的使用情况,并了解其使用的潜在危险因素。还评估了这些疗法的主观反应及其对治疗依从性的影响。
方法:前瞻性、描述性和横断面研究。根据人口统计学和临床特征对炎症性肠病患者进行分类。收集了一份关于补充和替代医学使用情况的问卷。
结果:共纳入 705 例患者。126 例(23%)患者使用了补充和替代医学。最常用的是草药(n=61)、顺势疗法(n=36)、针灸(n=31)、开菲尔(n=31)和芦荟(n=25)。使用补充和替代医学的相关因素是肠外表现(OR 1.69,95%CI 1.11-2.57)和疾病的长期演变(OR 2.08,95%CI 1.44-2.99)。大多数患者(74%)主观感觉使用补充和替代医学并没有改善他们的病情,11 例患者出现与使用相关的不良事件,11%的患者停止使用常规药物。
结论:炎症性肠病患者中补充和替代医学的使用较为频繁,尤其是在有肠外表现和长期病程的患者中。这些治疗方法的使用并未被患者认为是有益的。
Am J Gastroenterol. 2002-2
Aliment Pharmacol Ther. 2011-12-18
Aliment Pharmacol Ther. 2006-2-1
Am J Gastroenterol. 1998-5
World J Gastroenterol. 2025-7-21
Crohns Colitis 360. 2024-5-9
World J Gastroenterol. 2015-3-28
World J Gastroenterol. 2014-9-7